Effect of nonsurgical periodontal treatment in patients with periodontitis and rheumatoid arthritis: A systematic review

F-J Silvestre, J Silvestre-Rangil, L Bagán, J-V Bagán, F-J Silvestre, J Silvestre-Rangil, L Bagán, J-V Bagán

Abstract

Background: Periodontitis has been regarded as a potential risk factor for rheumatoid arthrosis (RA). A systematic review is made to determine whether nonsurgical periodontal treatment in patients with RA offers benefits in terms of the clinical activity and inflammatory markers of the disease.

Material and methods: A search was made of the Medline-PubMed, Cochrane, Embase and Scopus databases to identify studies on the relationship between the two disease processes, and especially on the effects of nonsurgical treatment in patients of this kind. The search was based on the following keywords: rheumatoid arthritis AND periodontitis (MeSH), rheumatoid arthritis AND periodontal treatment.

Results: Eight articles on the nonsurgical treatment of patients with periodontitis and RA were finally included in the study. All of them evaluated clinical (DAS28) and laboratory test activity (ESR, CRP, IL-6, TNFα) before and after treatment. A clear decrease in DAS28 score and ESR was recorded, while other parameters such as CRP, IL-6 and TNFα showed a nonsignificant tendency to decrease as a result of treatment.

Conclusions: Nonsurgical treatment improved the periodontal condition of patients with periodontitis and RA, with beneficial effects upon the clinical and laboratory test parameters (DAS28 and ESR), while other inflammatory markers showed a marked tendency to decrease. However, all the studies included in the review involved small samples sizes and follow-up periods of no more than 6 months. Larger and particularly longitudinal studies are therefore needed to more firmly establish possible significant relations between the two disease processes.

Conflict of interest statement

Conflict of interest statement: The authors have declared that no conflict of interest exist.

References

    1. Linden GJ, Lyons A, Scannapieco FA. Periodontal systemic associations: review of the evidence. J Clin Periodontol. 2013;40 Suppl.14:S8–19.
    1. Loyola-Rodriguez JP, Martinez-Martinez RE, Abud-Mendoza C, Patiño-Marin N, Seymour GJ. Rheumatoid arthritis and the role of oral bacteria. J Oral Microbiol. 2010;2:5784.
    1. Weyand CM. New insights into the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 2000;39 Suppl 1:3–8.
    1. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990;33:305–15.
    1. Kobayashi T, Murasawa A, Komatsu Y, Yokoyama T, Ishida K, Abe A. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults. J Periodontol. 2010;81:650–7.
    1. Ishida K, Kobayashi T, Ito S, Komatsu Y, Yokoyama T, Okada M. Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. J Periodontol. 2012;83:917–25.
    1. Sakkas LI, Bogdanos DP, Katsiari C, Platsoucas CD. Anti-citrullined peptides as autoantigens in rheumatoid arthritis- relevance to treatment. Autoimmun Rev. 2014;13:114–20.
    1. Konig MF, Paracha AS, Moni M, Bingham CO, Andrade F. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology. Ann Rheum Dis. 2015;74:2054–61.
    1. Mikuls TR, Paune JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Reumatol. 2014;66:1090–100.
    1. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentación rate in patients with rheumatoid arthritis. J Rheumatol. 1997;24:1477–85.
    1. Ribeiro J, Leão A, Novaes AB. Periodontal infection as a posible severity factor for rheumatoid arthritis. J Clin Periodontol. 2005;32:412–6.
    1. Al-katma MK, Bissada NF, Bordeaux JM, Sue J, Askari AD. Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol. 2007;13:134–7.
    1. Ortiz P, Bissada NF, Palomo L, Han YW, Al-Zahrani MS, Panneerselvam A. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol. 2009;80:535–40.
    1. Pinho MN, Oliveira RD, Novaes AB Jr, Voltarelli JC. Relationship between periodontitis and rheumatoid arthritis and the effect of non-surgical periodontal treatment. Braz Dent J. 2009;20:355–64.
    1. Ranade SB, Doiphode S. Is there a relationship between periodontitis and rheumatoid arthritis? J Indian Soc Periodontol. 2012;16:22–7.
    1. Okada M, Kobayashi T, Ito S, Yokoyama T, Abe A, Murasawa A. Periodontal treatment decreases levels of antibodies to Prophyromonas gingivalis and citrulline in patients with reumatoid arthritis and periodontitis. J Periodontol. 2013;84:e74–84.
    1. Biyikoğlu B, Buduneli N, Aksu K, Nalbantsoy A, Lappin DF, Evrenosoğlu E. Periodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients. Rheumatol Int. 2013;33:2607–16.
    1. Monsarrat P, Vergnes JN, Cantagrel A, Algans N, Cousty S, Kémoun P. Effect of periodontal treatment on the clinical parameters of patients with rheumatoid arthritis: study protocol of the randomized, controlled ESPERA trail. Trials. 2013;14:253.
    1. Kaur S, Bright R, Proudman SM, Bartold PM. Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis?. A systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44:113–22.
    1. Hajishengallis G, Moutsopoulos NM. Etiology of leukocyte adhesión deficiency-associated periodontitis revisited: not a raging infection but a raging inflammatory response. Expert Rev Clin Immunol. 2014;10:973–5.
    1. Hajishengallis G. The inflammophilic carácter of the periodontitis-associated microbiota. Mol Oral Microbiol. 2014;29:248–57.
    1. Wegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, Feldmann M. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev. 2010;233:34–54.
    1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
    1. Haro25 I, Gómara MJ. The use of citrullinated peptides for the diagnosis and prognosis of rheumatoid arthritis. Curr Top Med Chem. 2014;14:2729–33.
    1. Hsu PC, Liao YF, Lin CL, Lin WH, Liu GY, Hung HC. Vimentin is involved in peptidylarginine 2-induced apoptosis of activated Jurkat cells. Mol Cells. 2014;37:426–34.
    1. Soós27 L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. J Rheumatol. 2007;34:1658–63.
    1. Sakkas LI, Bogdanos DP, Katsiari C, Platsoucas CD. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment. Autoimmun Rev. 2014;13:1114–20.
    1. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes:genes, features and involvement in disease. Bioessays. 2003;25:1106–18.
    1. Inagaki M, Takahara H, Nishi Y, Sugawara K, Sato C. Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. J Biol Chem. 1989;264:18119–27.
    1. Auger I, Balandraud N, Rak J, Lambert N, Martin M, Roudier J. New autoantigens in rheumatoid arthritis (RA). Screening 8268 proteins arrays with será from patients with RA. Ann Rheum Dis. 2009;68:591–4.
    1. Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T. The major sinovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol. 2001;166:4177–84.
    1. Serre G. Autoantibodies to filaggrin/deiminated fibrin (AFA) are useful for the diagnosis and prognosis of rheumatoid arthritis, and are probably involved in the pathophysiology of the disease. Joint Bone Spine. 2001;68:103–5.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner